Millie Nelson

Editor

Millie Nelson is Partnering and Investment senior editor at BioXconomy, where she covers deals and dealmakers across the life-sciences sector, following partnerships, licensing agreements and investment trends across biotechnology and pharma. She studied English Literature at university before starting her journalism career as a reporter, going on to become editor of BioProcess Insider, the deals and business title that preceded her current role. She has also written for BioProcess International, and her reporting focuses on making the commercial mechanics of the biotech industry, from term sheets to M&A, accessible to a specialist audience.